Phreesia Inc
$ 17.00
-0.12%
29 Dec - close price
- Market Cap 1,026,085,000 USD
- Current Price $ 17.00
- High / Low $ 17.33 / 16.80
- Stock P/E N/A
- Book Value 5.32
- EPS -0.09
- Next Earning Report 2026-04-01
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA N/A %
- ROE -0.02 %
- 52 Week High 32.76
- 52 Week Low 15.41
About
Phreesia, Inc. is a premier provider of SaaS solutions and payment platforms specifically designed for the healthcare industry, primarily serving clients in the United States and Canada. Based in Raleigh, North Carolina, Phreesia employs cutting-edge technology to improve patient engagement and optimize operational workflows for healthcare providers. Its robust suite of solutions enables efficient patient check-in, streamlined data collection, and seamless payment processing, thereby enhancing administrative efficiency while elevating the overall patient experience. As healthcare moves toward more patient-centric models, Phreesia is well-positioned to empower organizations in achieving transformative improvements in care delivery and operational effectiveness.
Analyst Target Price
$29.82
Quarterly Earnings
| Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | Jul 2023 | Apr 2023 | Jan 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-12-08 | 2025-09-04 | 2025-05-28 | 2025-03-12 | 2024-12-09 | 2024-09-04 | 2024-05-30 | 2024-03-14 | 2023-12-05 | 2023-09-06 | 2023-05-31 | 2023-03-22 |
| Reported EPS | 0.3121 | 0.01 | 0.2259 | 0.1848 | 0.0367 | -0.31 | -0.35 | -0.21 | -0.25 | -0.34 | -0.38 | -0.43 |
| Estimated EPS | -0.0014 | -0.06 | -0.42 | 0.1106 | -0.27 | -0.36 | -0.48 | -0.26 | -0.36 | -0.42 | -0.46 | -0.51 |
| Surprise | 0.3135 | 0.07 | 0.6459 | 0.0742 | 0.3067 | 0.05 | 0.13 | 0.05 | 0.11 | 0.08 | 0.08 | 0.08 |
| Surprise Percentage | 22392.8571% | 116.6667% | 153.7857% | 67.0886% | 113.5926% | 13.8889% | 27.0833% | 19.2308% | 30.5556% | 19.0476% | 17.3913% | 15.6863% |
Next Quarterly Earnings
| Jan 2026 | |
|---|---|
| Reported Date | 2026-04-01 |
| Fiscal Date Ending | 2026-01-31 |
| Estimated EPS | 0.0221 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PHR
2025-12-30 10:08:52
Phreesia (NYSE: PHR) has achieved a Top 10 ranking on The Software Report’s Top 50 Software Companies of 2025, marking its fourth consecutive appearance and its highest position yet. This recognition underscores the company's innovation in healthcare technology, particularly with the introduction of Phreesia VoiceAI, which aims to simplify patient and provider experiences. The achievement highlights the growing importance of digital tools and conversational automation in streamlining healthcare operations and improving patient engagement.
2025-12-23 09:08:48
Phreesia's stock has seen a significant downturn, but the author believes this presents a compelling buying opportunity. The article suggests that despite the poor performance, the company's valuation and growth prospects remain strong.
2025-12-20 07:08:53
Phreesia, Inc. reported a significant financial turnaround in its fiscal third quarter, achieving profitability with $4.3 million in net income and strong cash generation. The healthcare technology company saw revenue climb 13 percent to $120.3 million, driven by client growth and increased revenue per customer. The company also completed its $160 million acquisition of AccessOne and raised its financial outlook for fiscal years 2026 and 2027, anticipating continued growth and operational efficiency.
2025-12-20 07:08:53
Phreesia reported a swing to profitability, with strong revenue growth and an improved outlook. The company also announced the acquisition of AccessOne, enhancing its payment platform with patient financing solutions, and detailed several new client partnerships.
2025-12-18 21:09:59
Phreesia, a leader in patient intake, outreach, and activation, has been recognized by The Software Report as one of the "Top 50 Software Companies of 2025" for the fourth consecutive year. This year marks Phreesia's first time ranking among the Top 10, highlighting its product excellence, organizational strength, and significant impact on the software industry, particularly with innovations like Phreesia VoiceAI. The company continues its commitment to improving healthcare experiences for patients and providers.
2025-12-18 11:09:50
Squarepoint Ops LLC significantly increased its stake in Phreesia, Inc. (NYSE:PHR) during Q2, purchasing 71,553 additional shares to bring its total holdings to 100,922 shares valued at $2.87 million. Other institutional investors also boosted their positions in the healthcare IT company, which saw insider selling over the past three months. Analysts maintain a "Moderate Buy" rating with a consensus price target of $31.00, despite the company trading around $16.28 and reporting negative margins, though it did beat quarterly earnings expectations.
